(Q34551093)

3 August 2017

Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death (English)

1 reference

3 August 2017

0 references

0 references

Douglas M Heuman

1

1 reference

3 August 2017

Souheil G Abou-Assi

2

1 reference

3 August 2017

Adil Habib

3

1 reference

3 August 2017

Leslie M Williams

4

1 reference

3 August 2017

R Todd Stravitz

5

1 reference

3 August 2017

Arun J Sanyal

6

1 reference

3 August 2017

Robert A Fisher

7

1 reference

3 August 2017

Anastasios A Mihas

8

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

3 August 2017

1 reference

3 August 2017

40

1 reference

3 August 2017

4

1 reference

3 August 2017

802-810

1 reference

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

3 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

The new liver allocation system: moving toward evidence-based transplantation policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

MELD and PELD: application of survival models to liver allocation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

A model to predict survival in patients with end-stage liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

Longitudinal assessment of mortality risk among candidates for liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

Is the change in MELD score a better indicator of mortality than baseline MELD score?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

RENAL FAILURE IN PATIENTS WITH CIRRHOSIS OF THE LIVER. I. CLINICAL AND PATHOLOGIC CHARACTERISTICS

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

Prognostic value of spontaneous hyponatremia in cirrhosis with ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

Compensated cirrhosis: Natural history and prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

A prognostic model for predicting survival in cirrhosis with ascites.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

Model for end-stage liver disease (MELD) and allocation of donor livers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: one more positive answer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

Pathophysiology of ascites and functional renal failure in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

The North American Study for the Treatment of Refractory Ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

Paracentesis with Intravenous Infusion of Albumin as Compared with Peritoneovenous Shunting in Cirrhosis with Refractory Ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

Dilutional hyponatremia in patients with cirrhosis and ascites.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

MELD score predicts 1-year patient survival post-orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840400409

7 January 2021

Identifiers

DOI

10.1002/HEP.1840400409

1 reference

3 August 2017

1 reference